<unk>  (EHHB/OHPC/THHB), sold under the brand name Trinestril AP, is an injectable combination medication of estradiol<unk>  (EHHB), an estrogen, hydroxyprogesterone caproate (OHPC), a progestogen, and testosterone<unk>  (THHB), an androgen/anabolic steroid. It contained 3 mg EHHB, 75 mg OHPC, and 100 mg THHB and was administered by intramuscular injection once per month. The medication was marketed by 1957.
Estradiol hexahydrobenzoate/hydroxyprogesterone caproate/testosterone hexahydrobenzoate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone caproate
Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate
Estradiol benzoate/testosterone isobutyrate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate
Testosterone acetate/testosterone undecanoate/testosterone valerate
Estradiol benzoate/estradiol phenylpropionate/testosterone propionate/testosterone phenylpropionate/testosterone isocaproate